Artivion, Inc. (AORT) stock
AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/3021% above fair value
$19.10−0.30 (-1.55%)
Close on Nov 13, 2026Market cap $931.24MP/E –Yield –
Artivion cash
Cash and short-term investments held at the end of each period.
Artivion's cash was $48.40M at Sep 30, 2026. For fiscal 2025 it was $64.91M, up 21.4% from the year before. Over ten years it grew 4.1% a year on average. The highest annual figure on record is $64.91M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.91M | +21.4% |
| FY2024 | Dec 31, 2024 | $53.46M | -9.3% |
| FY2023 | Dec 31, 2023 | $58.94M | +49.8% |
| FY2022 | Dec 31, 2022 | $39.35M | -28.5% |
| FY2021 | Dec 31, 2021 | $55.01M | -11.2% |
| FY2020 | Dec 31, 2020 | $61.96M | +80.7% |
| FY2019 | Dec 31, 2019 | $34.29M | -18.8% |
| FY2018 | Dec 31, 2018 | $42.24M | +3.6% |
| FY2017 | Dec 31, 2017 | $40.75M | -28.9% |
| FY2016 | Dec 31, 2016 | $57.34M | +32.1% |
| FY2015 | Dec 31, 2015 | $43.42M | +30.1% |
| FY2014 | Dec 31, 2014 | $33.38M | -11.3% |
| FY2013 | Dec 31, 2013 | $37.64M | +189.4% |
| FY2012 | Dec 31, 2012 | $13.01M | -40.1% |
| FY2011 | Dec 31, 2011 | $21.71M | -38.9% |
| FY2010 | Dec 31, 2010 | $35.50M | +17.8% |
| FY2009 | Dec 31, 2009 | $30.12M | +75.1% |
| FY2008 | Dec 31, 2008 | $17.20M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $48.40M | -34.1% |
| Q2 FY2026 | Jun 30, 2026 | $77.32M | +44.6% |
| Q1 FY2026 | Mar 31, 2026 | $55.76M | +47.9% |
| Q4 FY2025 | Dec 31, 2025 | $64.91M | +21.4% |
| Q3 FY2025 | Sep 30, 2025 | $73.43M | +30.7% |
| Q2 FY2025 | Jun 30, 2025 | $53.48M | -2.8% |
| Q1 FY2025 | Mar 31, 2025 | $37.69M | -26.3% |
| Q4 FY2024 | Dec 31, 2024 | $53.46M | -9.3% |
| Q3 FY2024 | Sep 30, 2024 | $56.17M | +5.0% |
| Q2 FY2024 | Jun 30, 2024 | $55.02M | +12.8% |
| Q1 FY2024 | Mar 31, 2024 | $51.12M | +66.1% |
| Q4 FY2023 | Dec 31, 2023 | $58.94M | +49.8% |
| Q3 FY2023 | Sep 30, 2023 | $53.48M | +42.3% |
| Q2 FY2023 | Jun 30, 2023 | $48.78M | +20.8% |
| Q1 FY2023 | Mar 31, 2023 | $30.77M | -40.1% |
| Q4 FY2022 | Dec 31, 2022 | $39.35M | -28.5% |
| Q3 FY2022 | Sep 30, 2022 | $37.57M | -42.3% |
| Q2 FY2022 | Jun 30, 2022 | $40.38M | -20.9% |
| Q1 FY2022 | Mar 31, 2022 | $51.41M | -10.0% |
| Q4 FY2021 | Dec 31, 2021 | $55.01M | -11.2% |
| Q3 FY2021 | Sep 30, 2021 | $65.13M | +0.8% |
| Q2 FY2021 | Jun 30, 2021 | $51.03M | -59.5% |
| Q1 FY2021 | Mar 31, 2021 | $57.10M | -10.6% |
| Q4 FY2020 | Dec 31, 2020 | $61.96M | +80.7% |
| Q3 FY2020 | Sep 30, 2020 | $64.64M | +73.9% |
| Q2 FY2020 | Jun 30, 2020 | $126.12M | +213.3% |
| Q1 FY2020 | Mar 31, 2020 | $63.88M | +55.5% |
| Q4 FY2019 | Dec 31, 2019 | $34.29M | -18.8% |
| Q3 FY2019 | Sep 30, 2019 | $37.18M | +5.3% |
| Q2 FY2019 | Jun 30, 2019 | $40.26M | +56.5% |
| Q1 FY2019 | Mar 31, 2019 | $41.08M | +50.0% |
| Q4 FY2018 | Dec 31, 2018 | $42.24M | +3.6% |
| Q3 FY2018 | Sep 30, 2018 | $35.31M | -35.8% |
| Q2 FY2018 | Jun 30, 2018 | $25.72M | -51.0% |
| Q1 FY2018 | Mar 31, 2018 | $27.39M | -54.0% |
| Q4 FY2017 | Dec 31, 2017 | $40.75M | -28.9% |
| Q3 FY2017 | Sep 30, 2017 | $55.01M | – |
| Q2 FY2017 | Jun 30, 2017 | $52.51M | – |
| Q1 FY2017 | Mar 31, 2017 | $59.60M | – |
| Q4 FY2016 | Dec 31, 2016 | $57.34M | – |
See a number that looks wrong?